Mutational analysis of caspase genes in prostate carcinomas

APMIS

Volumn 118, Issue 4, 2010, Pages 308-312

  Kim, Min Sung ^a   Park, Sang Wook ^a   Kim, Yoo Ri ^a   Lee, Ji Youl ^a   Lim, Hyeon Woo ^a   Song, Sang Yong ^b   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Apoptosis; Caspase; Mutation; Prostate cancer

Indexed keywords

CASPASE; CASPASE 10; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME;

ADULT; AGED; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

ADENOCARCINOMA; APOPTOSIS; CASPASES; DNA MUTATIONAL ANALYSIS; HUMANS; MALE; MICRODISSECTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS;

EID: 77949903312     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02592.x     Document Type: Article

References (32)

1. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000 39 : 1415 1430.
2. Nagata S. Apoptosis by death factor. Cell 1997 88 : 355 365.
3. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999 6 : 1028 1042.
4. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ 1999 6 : 1060 1066.
5. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992 356 : 768 774.
6. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004 117 : 561 574.
7. Hu S, Snipas SJ, Vincenz C, Salvesen G, Dixit VM. Caspase-14 is a novel developmentally regulated protease. J Biol Chem 1998 273 : 29648 29653.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000 100 : 57 70.
9. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 1999 6 : 33 7.
10. Schwartz S Jr., Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999 59 : 2995 3002.
11. Soung YH, Lee JW, Kim HS, Park WS, Kim SY, Lee JH, et al. Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 2003 22 : 8048 8052.
12. Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH, et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003 125 : 708 715.
13. Soung YH, Lee JW, Kim SY, Jang J, Park YG, Park WS, et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005 65 : 815 821.
14. Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, et al. Somatic mutations of CASP3 gene in human cancers. Hum Genet 2004 115 : 112 115.
15. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002 99 : 4094 4099.
16. Soung YH, Jeong EG, Ahn CH, Kim SS, Song SY, Yoo NJ, et al. Mutational analysis of caspase 1, 4, and 5 genes in common human cancers. Hum Pathol 2008 39 : 895 900.
17. Kim YR, Kim KM, Yoo NJ, Lee SH. Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors. Hum Pathol 2009 40 : 868 871.
18. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999 18 : 3754 3760.
19. Shin MS, Kim HS, Lee SH, Park WS, Kim SY, Park JY, et al. Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res 2001 61 : 4942 4946.
20. Chow SC, Shao J, Wang H. Comparing means. In : Sample Size Calculations in Clinical Research. Chow SC, Shao J, Wang H, editors. New York : Chapman & Hall, 2008 : 47 80.
21. Lee SH, Stehlik C, Reed JC. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 2001 276 : 34495 34500.
22. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993 2 : 338 346.
23. Shankar S, Singh TR, Srivastava RK. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: intracellular mechanisms. Prostate 2004 61 : 35 49.
24. Eid MA, Lewis RW, Abdel-Mageed AB, Kumar MV. Reduced response of prostate cancer cells to TRAIL is modulated by NFkappaB-mediated inhibition of caspases and Bid activation. Int J Oncol 2002 21 : 111 117.
25. Takayama H, Takakuwa T, Dong Z, Nonomura N, Okuyama A, Nagata S, et al. Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens. Lab Invest 2001 81 : 283 288.
26. O'Kane HF, Watson CJ, Johnston SR, Petak I, Watson RW, Williamson KE. Targeting death receptors in bladder, prostate and renal cancer. J Urol 2006 175 : 432 438.
27. Kim SY, Song SY, Kim MS, Lee JY, Lee HM, Choi HY, et al. Immunohistochemical analysis of Fas and FLIP in prostate cancers. APMIS 2009 117 : 28 33.
28. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001 61 : 1227 1232.
29. O'Neill AJ, Boran SA, O'Keane C, Coffey RN, Hegarty NJ, Hegarty P, et al. Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma. Prostate 2001 47 : 183 188.
30. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997 275 : 967 969.
31. Kondo S, Shinomura Y, Miyazaki Y, Kiyohara T, Tsutsui S, Kitamura S, et al. Mutations of the bak gene in human gastric and colorectal cancers. Cancer Res 2000 60 : 4328 4330.
32. Lee JW, Soung YH, Kim SY, Nam SW, Kim CJ, Cho YG, et al. Inactivating mutations of proapoptotic Bad gene in human colon cancers. Carcinogenesis 2004 25 : 1371 1376.